|
GB0515035D0
|
|
Treatment of atherosclerotic conditions
|
|
GB0503940D0
|
|
Assay methods
|
|
GB0503939D0
|
|
Chlamydia detection
|
|
GB0424552D0
|
|
Methods and means
|
|
GB0402578D0
|
|
Methods of treatment of atherosclerosis
|
|
GB0323348D0
|
|
Methods and means for modulating lipid metabolism
|
|
US7504226B2
|
|
Methods relating to treatment of atherosclerosis
|
|
WO03017992A2
|
|
Means for treatment of atherosclerosis
|
|
GB0216754D0
|
|
Therapeutic methods and means
|
|
GB0216755D0
|
|
Methods and means
|
|
GB0216530D0
|
|
Methods and means
|
|
GB0216529D0
|
|
Methods and means
|
|
GB0204611D0
|
|
Methods of measurement
|
|
GB0202774D0
|
|
Methods and means
|
